April 24, 2018 – Genomenon’s Machine Learning Algorithm Identifies Key Biomarkers for Rare Genetic Disorders of Obesity
Genomenon, the leading genomic data search company, today announced a partnership with Rhythm Pharmaceuticals, a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, to create a database of genetic mutations associated with obesity as documented in the medical literature. Continue Reading….
Mastermind Uses Machine Learning to Prioritize Medical Literature According to ACMG Variant Interpretation Guidelines Continue Reading….
April 2, 2018 – Genomenon Partners with Veritas Genetics to Create Next Generation Genomic Literature Prioritization Engine Powered By Machine Learning and AI
Companies Collaborate to Aggressively Reduce the Time and Cost of Variant Interpretation to Further Scale Global Adoption of Whole Genome Sequencing Continue Reading….
GenomeNext and Genomenon Partner to Speed Variant Curation for Whole Exome and Whole Genome Analysis. Continue Reading….
The Mastermind now provides a link to VarSome for gene and variant information from 30 different genomic databases. VarSome includes a link to Mastermind search results for the scientific literature related to each variant and gene in VarSome. Continue Reading….
Genomenon Presents Details of a Pan-Hematopoietic Malignancy Gene Panel with with Supporting Evidence. Continue Reading….
October 18th, 2017 – LifeOmic Leverages Genomenon’s Mastermind Genomic Search Engine for Variant Intrepretation
LifeOmic Partners with Genomenon to Streamline Genomic Interpretation of Whole Genomes Continue Reading….
Genomenon is offering a Free Edition of the Mastermind Genomic Search Engine to clinical, research and academic institutions to advance genomic analysis. Continue Reading….
New Product Dramatically Accelerates Genetic Variant Curation – Speeding Time to Patient Diagnosis. Continue Reading….
Genomenon Inc., a DNA interpretation software company, today announced the completion of a $1.8M investment. Continue Reading….
Genomenon’s Board of Directors recently appointed Mike Klein to the position of Chief Executive Officer as the company prepares to launch its first product, Mastermind, the worlds first genomic search engine. Continue Reading….